Studies in myasthenia gravis: Pyridostigmine-C14metabolism after thymectomy

Peter Kornfeld; Thomas N. Mittag; Gabriel Genkins; Steven Horowitz; Angelos E. Papatestas; Charles Woo

doi:10.1212/wnl.25.10.998

Studies in myasthenia gravis: Pyridostigmine-C¹⁴metabolism after thymectomy

Peter Kornfeld
, Thomas N. Mittag
, Gabriel Genkins
, Steven Horowitz
, Angelos E. Papatestas
, Charles Woo

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Pyridostigmine-carbon14 (P-C¹⁴) excretion studies in myasthenia gravis patients who had had thymectomies failed to produce any significant difference from results observed in myasthenic patients who had not had thyrnectomies. Thus, change in P-C¹⁴metabolism cannot help explain decreased anticholinesterase requirements and electromyographic changes observed in some patients following thymectomy.

Original language	English
Pages (from-to)	998-999
Number of pages	2
Journal	Neurology
Volume	25
Issue number	10
DOIs	https://doi.org/10.1212/wnl.25.10.998
State	Published - Oct 1975

Access to Document

10.1212/wnl.25.10.998

Cite this

@article{3c9d221160234349aec34557a12a9f22,

title = "Studies in myasthenia gravis: Pyridostigmine-C14metabolism after thymectomy",

abstract = "Pyridostigmine-carbon14 (P-C14) excretion studies in myasthenia gravis patients who had had thymectomies failed to produce any significant difference from results observed in myasthenic patients who had not had thyrnectomies. Thus, change in P-C14metabolism cannot help explain decreased anticholinesterase requirements and electromyographic changes observed in some patients following thymectomy.",

author = "Peter Kornfeld and Mittag, \{Thomas N.\} and Gabriel Genkins and Steven Horowitz and Papatestas, \{Angelos E.\} and Charles Woo",

year = "1975",

month = oct,

doi = "10.1212/wnl.25.10.998",

language = "English",

volume = "25",

pages = "998--999",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - Studies in myasthenia gravis

T2 - Pyridostigmine-C14metabolism after thymectomy

AU - Kornfeld, Peter

AU - Mittag, Thomas N.

AU - Genkins, Gabriel

AU - Horowitz, Steven

AU - Papatestas, Angelos E.

AU - Woo, Charles

PY - 1975/10

Y1 - 1975/10

N2 - Pyridostigmine-carbon14 (P-C14) excretion studies in myasthenia gravis patients who had had thymectomies failed to produce any significant difference from results observed in myasthenic patients who had not had thyrnectomies. Thus, change in P-C14metabolism cannot help explain decreased anticholinesterase requirements and electromyographic changes observed in some patients following thymectomy.

AB - Pyridostigmine-carbon14 (P-C14) excretion studies in myasthenia gravis patients who had had thymectomies failed to produce any significant difference from results observed in myasthenic patients who had not had thyrnectomies. Thus, change in P-C14metabolism cannot help explain decreased anticholinesterase requirements and electromyographic changes observed in some patients following thymectomy.

UR - https://www.scopus.com/pages/publications/0016721483

U2 - 10.1212/wnl.25.10.998

DO - 10.1212/wnl.25.10.998

M3 - Article

C2 - 1237111

AN - SCOPUS:0016721483

SN - 0028-3878

VL - 25

SP - 998

EP - 999

JO - Neurology

JF - Neurology

IS - 10

ER -

Studies in myasthenia gravis: Pyridostigmine-C14metabolism after thymectomy

Abstract

Access to Document

Fingerprint

Cite this

Studies in myasthenia gravis: Pyridostigmine-C¹⁴metabolism after thymectomy